United States Rivaroxaban Market Report 2016

October 2016 | 122 pages | ID: UE5464C0152EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Rivaroxaban

Revenue, means the sales value of Rivaroxaban

This report studies sales (consumption) of Rivaroxaban in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer Healthcare AG (Germany)
• GlaxoSmithKline Plc. (UK)
• Boehringer Ingelheim (Germany)
• Sanofi S.A. (France)
• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bristol-Myers Squibb Company (US)
• Eisai Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Rivaroxaban in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Rivaroxaban Market Report 2016

1 RIVAROXABAN OVERVIEW

1.1 Product Overview and Scope of Rivaroxaban
1.2 Classification of Rivaroxaban
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Rivaroxaban
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Rivaroxaban (2011-2021)
  1.4.1 United States Rivaroxaban Sales and Growth Rate (2011-2021)
  1.4.2 United States Rivaroxaban Revenue and Growth Rate (2011-2021)

2 UNITED STATES RIVAROXABAN COMPETITION BY MANUFACTURERS

2.1 United States Rivaroxaban Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Rivaroxaban Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Rivaroxaban Average Price by Manufactures (2015 and 2016)
2.4 Rivaroxaban Market Competitive Situation and Trends
  2.4.1 Rivaroxaban Market Concentration Rate
  2.4.2 Rivaroxaban Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES RIVAROXABAN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Rivaroxaban Sales and Market Share by Type (2011-2016)
3.2 United States Rivaroxaban Revenue and Market Share by Type (2011-2016)
3.3 United States Rivaroxaban Price by Type (2011-2016)
3.4 United States Rivaroxaban Sales Growth Rate by Type (2011-2016)

4 UNITED STATES RIVAROXABAN SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Rivaroxaban Sales and Market Share by Application (2011-2016)
4.2 United States Rivaroxaban Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES RIVAROXABAN MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Rivaroxaban Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
  5.2.2 Rivaroxaban Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer Healthcare AG (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
  5.3.2 Rivaroxaban Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc. (UK) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
  5.4.2 Rivaroxaban Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Boehringer Ingelheim (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
  5.5.2 Rivaroxaban Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Sanofi S.A. (France) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
  5.6.2 Rivaroxaban Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Abbott India Limited (India) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
  5.7.2 Rivaroxaban Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Aspen Holdings (South Africa) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
  5.8.2 Rivaroxaban Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bristol-Myers Squibb Company (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
  5.9.2 Rivaroxaban Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Eisai Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  5.10.2 Rivaroxaban Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)

6 RIVAROXABAN MANUFACTURING COST ANALYSIS

6.1 Rivaroxaban Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Rivaroxaban

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Rivaroxaban Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Rivaroxaban Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES RIVAROXABAN MARKET FORECAST (2016-2021)

10.1 United States Rivaroxaban Sales, Revenue Forecast (2016-2021)
10.2 United States Rivaroxaban Sales Forecast by Type (2016-2021)
10.3 United States Rivaroxaban Sales Forecast by Application (2016-2021)
10.4 Rivaroxaban Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Rivaroxaban
Table Classification of Rivaroxaban
Figure United States Sales Market Share of Rivaroxaban by Type in 2015
Table Application of Rivaroxaban
Figure United States Sales Market Share of Rivaroxaban by Application in 2015
Figure United States Rivaroxaban Sales and Growth Rate (2011-2021)
Figure United States Rivaroxaban Revenue and Growth Rate (2011-2021)
Table United States Rivaroxaban Sales of Key Manufacturers (2015 and 2016)
Table United States Rivaroxaban Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Rivaroxaban Sales Share by Manufacturers
Figure 2016 Rivaroxaban Sales Share by Manufacturers
Table United States Rivaroxaban Revenue by Manufacturers (2015 and 2016)
Table United States Rivaroxaban Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Rivaroxaban Revenue Share by Manufacturers
Table 2016 United States Rivaroxaban Revenue Share by Manufacturers
Table United States Market Rivaroxaban Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Rivaroxaban Average Price of Key Manufacturers in 2015
Figure Rivaroxaban Market Share of Top 3 Manufacturers
Figure Rivaroxaban Market Share of Top 5 Manufacturers
Table United States Rivaroxaban Sales by Type (2011-2016)
Table United States Rivaroxaban Sales Share by Type (2011-2016)
Figure United States Rivaroxaban Sales Market Share by Type in 2015
Table United States Rivaroxaban Revenue and Market Share by Type (2011-2016)
Table United States Rivaroxaban Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Rivaroxaban by Type (2011-2016)
Table United States Rivaroxaban Price by Type (2011-2016)
Figure United States Rivaroxaban Sales Growth Rate by Type (2011-2016)
Table United States Rivaroxaban Sales by Application (2011-2016)
Table United States Rivaroxaban Sales Market Share by Application (2011-2016)
Figure United States Rivaroxaban Sales Market Share by Application in 2015
Table United States Rivaroxaban Sales Growth Rate by Application (2011-2016)
Figure United States Rivaroxaban Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Rivaroxaban Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Rivaroxaban Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Rivaroxaban Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Rivaroxaban Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Rivaroxaban Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Rivaroxaban Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Rivaroxaban Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Rivaroxaban Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Rivaroxaban Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Rivaroxaban Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Rivaroxaban Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Rivaroxaban Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rivaroxaban
Figure Manufacturing Process Analysis of Rivaroxaban
Figure Rivaroxaban Industrial Chain Analysis
Table Raw Materials Sources of Rivaroxaban Major Manufacturers in 2015
Table Major Buyers of Rivaroxaban
Table Distributors/Traders List
Figure United States Rivaroxaban Production and Growth Rate Forecast (2016-2021)
Figure United States Rivaroxaban Revenue and Growth Rate Forecast (2016-2021)
Table United States Rivaroxaban Production Forecast by Type (2016-2021)
Table United States Rivaroxaban Consumption Forecast by Application (2016-2021)